Active immunity can last anywhere from a few months to a lifetime, depending on the pathogen involved and how immunity was acquired. Natural infection with measles, for example, typically produces lifelong protection, while immunity to influenza fades within a single season. The wide range exists because your immune system builds a different quality and durability of defense depending on the specific threat it encounters.
Why Some Immunity Lasts a Lifetime
When your body fights off an infection or responds to a vaccine, it doesn’t just produce antibodies for the moment. It creates specialized memory cells, both B cells and T cells, that stick around long after the initial threat is gone. These memory cells are essentially dormant sentinels. They don’t need the original pathogen to keep them alive; they simply wait, ready to reactivate faster and more forcefully if the same invader appears again.
The process that builds this long-term defense starts with rapid multiplication of immune cells that recognize the threat. Some of those cells become short-lived antibody factories that handle the immediate infection. Others enter a refinement process where they essentially “practice” making better-fitting antibodies through repeated rounds of mutation and selection. The cells that emerge from this process produce highly targeted, precise antibodies and can survive in your body for decades.
This is why measles infection produces lifelong immunity. The virus persists in immune tissue for months after infection, giving the immune system extended time to mature its response and build a deep reserve of high-quality memory cells. Diseases that trigger this kind of prolonged immune activation tend to leave the most durable protection behind.
How Long Specific Immunities Actually Last
The duration of active immunity varies enormously by disease. Here’s what the evidence shows for some common examples:
- Measles (natural infection): Lifelong. The immune response after wild infection is both more robust and longer-lasting than vaccine-induced immunity.
- Measles (vaccine): Protection from two doses of measles vaccine declines within 10 to 15 years, though it remains strong enough to prevent severe disease in most people for much longer.
- Hepatitis B (vaccine): Extremely durable. More than 90% of vaccinated people still show evidence of protection 30 years after completing the primary series.
- Polio (vaccine): Protective antibodies persist for at least 18 years after the last dose of either the oral or injected vaccine. Immunity against two of the three poliovirus types may effectively be lifelong.
- Tetanus (vaccine): Protection gradually fades, dropping below protective levels after about 10 years, which is why booster shots are recommended on that schedule.
- Pertussis/whooping cough (vaccine): The acellular vaccine’s effectiveness drops to about 84% within three years and continues to wane, requiring periodic boosters.
- COVID-19 (vaccine): Vaccine efficacy against symptomatic infection drops to roughly 47 to 69% within five months. Antibody levels against the spike protein fall by approximately 92% after seven months.
- Influenza (vaccine): Protection starts in the range of 40 to 60% and can decline to near zero by the end of flu season, particularly when circulating strains don’t match the vaccine well.
Why Some Immunity Fades Quickly
Two main forces cause active immunity to wane: your antibody levels naturally decline over time, and the pathogen itself may change enough that your existing immune memory no longer recognizes it well.
Circulating antibodies always drop after the initial immune response. This is normal biology, not a failure. For most diseases, falling antibody levels don’t mean you’ve lost protection, because your memory cells can rapidly produce new antibodies when re-exposed. The problem arises when the pathogen requires high antibody levels at the point of entry (like in the nose or throat) to prevent infection entirely, rather than just preventing severe illness. This is one reason respiratory viruses like influenza and SARS-CoV-2 are so hard to maintain full protection against.
Influenza presents a particularly challenging case. The virus mutates constantly through a process called antigenic drift, meaning last year’s immune memory may not recognize this year’s strain. This mutation pressure, combined with the natural decline in antibodies, is why annual vaccination is necessary rather than a one-time series.
COVID-19 follows a similar pattern. The rapid emergence of new variants means previously built immunity becomes less effective at recognizing the current version of the virus. Vaccine effectiveness against hospitalization holds up better than effectiveness against any infection, but even protection against severe outcomes declines over four to six months in older adults.
Active Immunity Versus Passive Immunity
Active immunity, whether from infection or vaccination, is fundamentally different from passive immunity. With active immunity, your body does the work of building its own defense, creating memory cells that can last years or a lifetime. Passive immunity means you receive pre-made antibodies from an outside source.
A newborn baby, for instance, receives passive immunity from its mother through the placenta. This borrowed protection is immediate but temporary, lasting only a few weeks or months before the antibodies break down. The baby’s immune system hasn’t learned anything from the experience, so once those maternal antibodies are gone, the protection disappears entirely. Active immunity takes several weeks to develop after exposure, but it is the only type that produces lasting protection.
What Makes Your Immunity Weaken Over Time
Age is the single biggest factor in how well your immune system maintains its defenses. As you get older, the thymus (the organ that produces new immune cells) gradually shrinks and produces fewer fresh T cells. This means your body has a harder time responding to new threats and maintaining the diversity of its immune memory. Older adults produce lower peaks of antibodies after vaccination, and those antibodies decline faster. This is a major reason why vaccine effectiveness against influenza hospitalization drops more steeply in older adults over four to six months.
The aging immune system also accumulates worn-out T cells that have lost their ability to function properly. Some become unresponsive to stimulation. Others lose the ability to multiply when they encounter a familiar pathogen. The body’s capacity to produce high-quality, precisely targeted antibodies also diminishes because key molecular processes involved in antibody refinement become less efficient with age.
Beyond aging, several other factors influence how long your immunity holds up. Chronic infections with viruses like cytomegalovirus (CMV) or Epstein-Barr virus can accelerate immune aging by forcing the immune system into a state of constant low-level activation. Chronic stress, smoking, heavy alcohol use, diabetes, autoimmune diseases, and long-term use of immune-suppressing medications all contribute to faster immune decline.
Nutrition plays a surprisingly direct role. Malnutrition weakens immune function broadly and increases susceptibility to infections. Specific nutrients matter too: vitamin A helps maintain the protective barriers in your respiratory and digestive tracts, vitamin D supports the activation of frontline immune defenses, vitamin E helps immune cells communicate properly, and zinc is essential for the function of more than 300 enzymes involved in immune activity. Caloric restriction (without malnutrition) has been shown to preserve the number and function of fresh immune cells in primates, and moderate exercise acts as a straightforward buffer against age-related immune decline.
How Doctors Check If You’re Still Protected
If you’re unsure whether a past vaccination or infection still protects you, a blood test called a titer can measure your antibody levels against a specific pathogen. For some diseases, clear protective thresholds exist. For influenza, an antibody titer of 1:40 is generally considered to provide about 50% protection against infection in healthy adults. For SARS-CoV-2, a neutralizing antibody titer of 1:80 or higher is considered indicative of a protective response, with titers of 1:250 or above associated with roughly 80% protection against symptomatic COVID-19.
Titer testing is most commonly used for hepatitis B, measles, mumps, rubella, and varicella, particularly for healthcare workers or people who can’t locate their vaccination records. Keep in mind that antibody levels tell only part of the story. Even when measurable antibodies are low, memory B and T cells may still be present and capable of mounting a rapid defense upon re-exposure. This is why some people with undetectable antibody levels can still fight off infections they were vaccinated against years ago.